These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8869817)

  • 21. Structures of mefenamic acid metabolites from human urine.
    Sato J; Yamane Y; Ito K; Bando H
    Biol Pharm Bull; 1993 Aug; 16(8):811-2. PubMed ID: 8220331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic activation of mefenamic acid leading to mefenamyl-S-acyl-glutathione adduct formation in vitro and in vivo in rat.
    Grillo MP; Tadano Lohr M; Wait JC
    Drug Metab Dispos; 2012 Aug; 40(8):1515-26. PubMed ID: 22577085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of some acyloxyethyl mefenamates as possible prodrugs.
    Jilani JA; Najib NM; Ghariabeh SH
    Acta Pharm Hung; 1997; 67(2-3):99-104. PubMed ID: 9223760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver.
    Wang M; Dickinson RG
    Drug Metab Dispos; 1998 Feb; 26(2):98-104. PubMed ID: 9456294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glyceride derivatives as potential prodrugs: synthesis, biological activity and kinetic studies of glyceride derivatives of mefenamic acid.
    Khan MS; Akhter M
    Pharmazie; 2005 Feb; 60(2):110-4. PubMed ID: 15739898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
    Dubois-Presle N; Lapicque F; Maurice MH; Fournel-Gigleux S; Magdalou J; Abiteboul M; Siest G; Netter P
    Mol Pharmacol; 1995 Mar; 47(3):647-53. PubMed ID: 7700262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity of gemfibrozil 1-o-beta-acyl glucuronide. Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats.
    Sallustio BC; Foster DJ
    Drug Metab Dispos; 1995 Sep; 23(9):892-9. PubMed ID: 8565777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the acyl-adenylate linked metabolite of mefenamic Acid.
    Horng H; Benet LZ
    Chem Res Toxicol; 2013 Mar; 26(3):465-76. PubMed ID: 23402341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human and rat liver UDP-glucuronosyltransferases are targets of ketoprofen acylglucuronide.
    Terrier N; Benoit E; Senay C; Lapicque F; Radominska-Pandya A; Magdalou J; Fournel-Gigleux S
    Mol Pharmacol; 1999 Jul; 56(1):226-34. PubMed ID: 10385704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible binding of zomepirac to plasma protein in vitro and in vivo.
    Smith PC; McDonagh AF; Benet LZ
    J Clin Invest; 1986 Mar; 77(3):934-9. PubMed ID: 3949982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of urinary pH on the pharmacokinetics of salicylic acid, with its glycine and glucuronide conjugates in human.
    Vree TB; Van Ewijk-Beneken Kolmer EW; Verwey-Van Wissen CP; Hekster YA
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):550-8. PubMed ID: 7834163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of benoxaprofen and flunoxaprofen acyl glucuronides in covalent binding to rat plasma and liver proteins in vivo.
    Dong JQ; Liu J; Smith PC
    Biochem Pharmacol; 2005 Sep; 70(6):937-48. PubMed ID: 16046212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective disposition of naproxen glucuronide in the rat.
    Iwaki M; Bischer A; Nguyen AC; McDonagh AF; Benet LZ
    Drug Metab Dispos; 1995 Oct; 23(10):1099-103. PubMed ID: 8654198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide.
    Sawamura R; Okudaira N; Watanabe K; Murai T; Kobayashi Y; Tachibana M; Ohnuki T; Masuda K; Honma H; Kurihara A; Okazaki O
    Drug Metab Dispos; 2010 Oct; 38(10):1857-64. PubMed ID: 20606003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins.
    Dubois N; Lapicque F; Maurice MH; Pritchard M; Fournel-Gigleux S; Magdalou J; Abiteboul M; Siest G; Netter P
    Drug Metab Dispos; 1993; 21(4):617-23. PubMed ID: 8104120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective reversible binding properties of the glucuronide conjugates of fenoprofen enantiomers to human serum albumin.
    Bischer A; Iwaki M; Zia-Amirhosseini P; Benet LZ
    Drug Metab Dispos; 1995 Sep; 23(9):900-3. PubMed ID: 8565778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparative chromatography of furosemide 1-O-acyl-glucuronide from urine using micronized amberiite XAD-2 and its application to other 1-O-acyl-glucuronides.
    Mizuma T; Benet LZ; Lin ET
    Prep Biochem Biotechnol; 1998 Feb; 28(1):37-47. PubMed ID: 9516641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HPLC/1H NMR spectroscopic studies of the reactive alpha-1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide.
    Corcoran O; Mortensen RW; Hansen SH; Troke J; Nicholson JK
    Chem Res Toxicol; 2001 Oct; 14(10):1363-70. PubMed ID: 11599927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
    Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH
    Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and analgesic activity of N-Arylhydrazone derivatives of mefenamic acid.
    Almasirad A; Tajik M; Bakhtiari D; Shafiee A; Abdollahi M; Zamani MJ; Khorasani R; Esmaily H
    J Pharm Pharm Sci; 2005 Sep; 8(3):419-25. PubMed ID: 16401392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.